Professor Stephen Gordon
- Professor, Clinical Sciences
- Centre for Drugs and Diagnostics
- Malawi-Liverpool-Wellcome Trust Research Programme (MLW)
Selected research publications
Machine learning-driven identification of serotype-independent pneumococcal vaccine candidates using samples from human infection challenge studies – Journal: Vaccine – Published: 7th March 2026
Pooled analysis of PCV13 efficacy from controlled human infection trials in Malawi and the UK – Journal: npj Vaccines – Published: 26th February 2026
The effect of pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine on nasopharyngeal colonisation following human infection challenge with serotype 3 and serotype 6B (PREVENTING PNEUMO 2): a double-masked, randomised, controlled, phase 4 trial – Journal: The Lancet Microbe – Published: 13th February 2026
Controlled human infection with Mycobacterium tuberculosis practical considerations for clinical trials – Journal: The Lancet Microbe – Published: 23rd January 2026
13-valent pneumococcal conjugate vaccine-induced B cells produce serotype 6B but not serotype 3 capsule-specific IgG antibodies in young Malawian adults – Journal: Vaccine – Published: 22nd January 2026
View more publications